Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Long-Term Deferred Tax (2020 - 2022)

Historic Long-Term Deferred Tax for IceCure Medical (ICCM) over the last 3 years, with Q4 2022 value amounting to $17.3 million.

  • IceCure Medical's Long-Term Deferred Tax rose 2184.13% to $17.3 million in Q4 2022 from the same period last year, while for Dec 2022 it was $17.3 million, marking a year-over-year increase of 2184.13%. This contributed to the annual value of $17.3 million for FY2022, which is 2184.13% up from last year.
  • Latest data reveals that IceCure Medical reported Long-Term Deferred Tax of $17.3 million as of Q4 2022, which was up 2184.13% from $14.2 million recorded in Q4 2021.
  • In the past 5 years, IceCure Medical's Long-Term Deferred Tax registered a high of $17.3 million during Q4 2022, and its lowest value of $12.0 million during Q4 2020.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $14.2 million (2021), whereas its average is $14.5 million.
  • Per our database at Business Quant, IceCure Medical's Long-Term Deferred Tax surged by 1793.96% in 2021 and then soared by 2184.13% in 2022.
  • Quarter analysis of 3 years shows IceCure Medical's Long-Term Deferred Tax stood at $12.0 million in 2020, then increased by 17.94% to $14.2 million in 2021, then rose by 21.84% to $17.3 million in 2022.
  • Its last three reported values are $17.3 million in Q4 2022, $14.2 million for Q4 2021, and $12.0 million during Q4 2020.